210 related articles for article (PubMed ID: 12518006)
1. Repeated mammographic screening reduces breast cancer mortality along the continuum of age.
Broeders MJ; Verbeek AL; Straatman H; Peer PG; Jong PC; Beex LV; Hendriks JH; Holland R
J Med Screen; 2002; 9(4):163-7. PubMed ID: 12518006
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of mammographic screening of the elderly: a case-referent study in the Nijmegen program in The Netherlands.
van Dijck JA; Holland R; Verbeek AL; Hendriks JH; Mravunac M
J Natl Cancer Inst; 1994 Jun; 86(12):934-8. PubMed ID: 8196083
[TBL] [Abstract][Full Text] [Related]
3. Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality.
Van Dijck JA; Verbeek AL; Beex LV; Hendriks JH; Holland R; Mravunac M; Straatman H; Werre JM
Int J Cancer; 1996 Jun; 66(6):727-31. PubMed ID: 8647640
[TBL] [Abstract][Full Text] [Related]
4. Effective biennial mammographic screening in women aged 40-49.
van Schoor G; Moss SM; Otten JD; Donders R; Paap E; den Heeten GJ; Holland R; Broeders MJ; Verbeek AL
Eur J Cancer; 2010 Dec; 46(18):3137-40. PubMed ID: 21036034
[TBL] [Abstract][Full Text] [Related]
5. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
6. Breast-cancer mortality in a non-randomized trial on mammographic screening in women over age 65.
Van Dijck JA; Verbeek AL; Beex LV; Hendriks JH; Holland R; Mravunac M; Straatman H; Werre JM
Int J Cancer; 1997 Jan; 70(2):164-8. PubMed ID: 9009155
[TBL] [Abstract][Full Text] [Related]
7. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
Jonsson H; Nyström L; Törnberg S; Lenner P
J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer screening by mammography in women aged under 50 years in Japan.
Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
[TBL] [Abstract][Full Text] [Related]
9. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point.
Tabar L; Duffy SW; Yen MF; Warwick J; Vitak B; Chen HH; Smith RA
J Med Screen; 2002; 9(4):159-62. PubMed ID: 12518005
[TBL] [Abstract][Full Text] [Related]
10. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
11. Mammography screening in the county of Fyn. November 1993-December 1999.
Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
[TBL] [Abstract][Full Text] [Related]
12. Biennial versus annual mammography and the risk of late-stage breast cancer.
White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
[TBL] [Abstract][Full Text] [Related]
13. Effect on breast cancer mortality of biennial mammographic screening of women under age 50.
Peer PG; Werre JM; Mravunac M; Hendriks JH; Holland R; Verbeek AL
Int J Cancer; 1995 Mar; 60(6):808-11. PubMed ID: 7896450
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of screening mammography. A meta-analysis.
Kerlikowske K; Grady D; Rubin SM; Sandrock C; Ernster VL
JAMA; 1995 Jan; 273(2):149-54. PubMed ID: 7799496
[TBL] [Abstract][Full Text] [Related]
15. Attending the breast screening programme after breast cancer treatment: a population-based study.
de Munck L; Kwast A; Reiding D; de Bock GH; Otter R; Willemse PH; Siesling S
Cancer Epidemiol; 2013 Dec; 37(6):968-72. PubMed ID: 24075800
[TBL] [Abstract][Full Text] [Related]
16. The relative effect of mammographic screening on breast cancer mortality by socioeconomic status.
Ripping TM; van der Waal D; Verbeek ALM; Broeders MJM
Medicine (Baltimore); 2016 Aug; 95(31):e4335. PubMed ID: 27495038
[TBL] [Abstract][Full Text] [Related]
17. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
Tabár L; Vitak B; Chen HH; Yen MF; Duffy SW; Smith RA
Cancer; 2001 May; 91(9):1724-31. PubMed ID: 11335897
[TBL] [Abstract][Full Text] [Related]
18. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
[TBL] [Abstract][Full Text] [Related]
19. Age-specific effectiveness of the Nijmegen population-based breast cancer-screening program: assessment of early indicators of screening effectiveness.
Peer PG; Holland R; Hendriks JH; Mravunac M; Verbeek AL
J Natl Cancer Inst; 1994 Mar; 86(6):436-41. PubMed ID: 8120918
[TBL] [Abstract][Full Text] [Related]
20. Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands.
van Gils CH; Otten JD; Verbeek AL; Hendriks JH; Holland R
J Epidemiol Community Health; 1998 Apr; 52(4):267-71. PubMed ID: 9616416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
